Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001209191-16-135310)

Filing Details

Accession Number:: 0001209191-16-135310
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2016-08-03 18:38:46
Reporting Period:: 2016-08-01

Filing Date:: 2016-08-03
Accepted Time:: 2016-08-03 18:38:46
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1438133	Tandem Diabetes Care Inc	TNDM	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1365369	F John Sheridan	C/O Tandem Diabetes Care, Inc., 11045 Roselle Street San Diego CA 92121	Evp, Chief Operating Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2016-08-01	15,000	$1.11	22,763	No	4	M	Direct
Common Stock	Disposition	2016-08-01	15,000	$6.52	7,763	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Options	Disposition	2016-08-01	15,000	$0.00	15,000	$1.11

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
87,040	2014-02-25	2023-04-23	No	4	M	Direct

Footnotes

The price reported is the weighted average price. The shares were sold in multiple transactions at prices ranging from $6.40 to $6.61. The reporting person undertakes to provide the SEC, the issuer, and any security holder full information regarding the number of shares and the prices at which the shares were sold.
The option became 25% exercisable on 2/25/2014 and in 36 equal monthly installments thereafter.